Notably, treatment of Pb K173-infected C57BL/6J mice with an IL-10R-neutralizing antibody (αIL-10R) conferred complete protection from MA-ARDS, as compared to isotype-treated mice (Fig. 4c and Supplementary Fig. 5b), while having no impact on eCM development (Fig. 4d and Supplementary Fig. 5c). This evidence concerns the gene IL10RA and microtia.